Ulrika Årehed Kågström reflects on World Cancer Leaders’ Summit 2023
Quoting Ulrika Årehed Kågström on LinkedIn:
”Just returned home from participating in the World Cancer Leaders’ Summit. It has been four years since we were last able to meet in this forum and it was fantastic to meet 350 leaders from 72 countries convening in Long Beach again.
The theme ‘Cancer in a changing world’ captured the big global challenges that the cancer community and wider health community face.
We discussed a gamut of pressing issues: from inequities in cancer care, the impact of climate change and crisis situations on cancer care, to disruptive technologies such as artificial intelligence in diagnosis and mRNA vaccines. Additional topics such as antimicrobial resistance and the obesity epidemic were also on the agenda.
During the meeting, the Latin American Code Against Cancer was launched. I had the privilege to give an opening speech where I emphasized the importance of the European code as a valuable tool in cancer prevention efforts and how Cancerfonden has utilized it.”
Source: Ulrika Årehed Kågström/LinkedIn
Ulrika Årehed Kågström is the President-Elect of the Union for International Cancer Control (UICC) and the Secretary-General of the Swedish Cancer Society. Prior to joining the Swedish Cancer Society, Ulrika was the Secretary-General at the Swedish Red Cross. She is also the chairperson of the Swedish Arts Council (appointed by the Government). At UICC, prior being elected as the President, Ulrika was the treasurer, chairman & member of the Knowledge, Advocacy and Policy Committee, chairman & member of the Finance Committee, member of the Strategy Review task force, member of the ATOM coalition task force, member of the Governance committee, member of the task force on AMR, member of the Advisory board of the Solidarity Fund for Ukraine and member of the Congress and Summit Committee.
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:17 27/11Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows